|
Integrated use of tumor AI volumetrics and advanced MRI to assess early response to Temferon in a phase 2 GBM trial: A novel paradigm. |
| |
|
Consulting or Advisory Role - Image Analysis Group |
Travel, Accommodations, Expenses - Image Analysis Group |
| |
|
Employment - Image Analysis Group |
Leadership - Image Analysis Group |
Stock and Other Ownership Interests - Image Analysis Group |
Travel, Accommodations, Expenses - Image Analysis Group |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Genenta Science |
Leadership - Genenta Science |
Stock and Other Ownership Interests - Genenta Science |
Honoraria - Genenta Science |
Consulting or Advisory Role - Genenta Science |
Travel, Accommodations, Expenses - Genenta Science |
| |
|
No Relationships to Disclose |